The problem of effective and safe treatment of acute respiratory infections in children
As the etiological structure of acute respiratory viral infections (ARVI) is polymorphic, the presence of clinical manifestations very rarely allows to establish a connection with a particular pathogen and to prescribe the proper causal treatment. The purpose of this clinical study was to examine th...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaslavsky O.Yu.
2017-02-01
|
| Series: | Zdorovʹe Rebenka |
| Subjects: | |
| Online Access: | http://childshealth.zaslavsky.com.ua/article/view/95015 |
| _version_ | 1819281723279540224 |
|---|---|
| author | T.A. Kruchko O.Ya. Tkachenko V.P. Harshman O.P. Ivanenko |
| author_facet | T.A. Kruchko O.Ya. Tkachenko V.P. Harshman O.P. Ivanenko |
| author_sort | T.A. Kruchko |
| collection | DOAJ |
| description | As the etiological structure of acute respiratory viral infections (ARVI) is polymorphic, the presence of clinical manifestations very rarely allows to establish a connection with a particular pathogen and to prescribe the proper causal treatment. The purpose of this clinical study was to examine the effectiveness of Imupret® in the treatment of acute respiratory viral infections in children (n = 35) of pre-school and primary school age. All patients received symptomatic treatment according to the current order of the Ministry of Healthcare of Ukraine. The main group (n = 18) received additional immunomodulatory herbal drug Imupret®. In order to monitor the course of ARVI, parents filled in the diaries, which included an assessment of nine core symptoms. In children of the main group, we noted improving the clinical index from the 3rd day compared to the controls. Significant differences were observed between patients, when assessing the nature of cough, namely its earlier moistening effect and increased productivity in children, who received additional Imupret® with complete regression in both groups up to the 12th day. The average duration of ARVI in the study group was 6.2 days compared with 8.9 days in the control group. Analyzing the incidence of respiratory diseases, we found out that within three months in the children, who were treated with Imupret®, recurrent episodes were observed in only 28 % of cases, whereas viral infection in children in the control group was registered in almost half of the cases. Imupret® is safe and effective drug of natural origin with a proven mechanism of action for the treatment and prevention of ARVI in children. |
| first_indexed | 2024-12-24T01:04:13Z |
| format | Article |
| id | doaj.art-8598c59d999a48c48db1edd8abf05ed7 |
| institution | Directory Open Access Journal |
| issn | 2224-0551 2307-1168 |
| language | English |
| last_indexed | 2024-12-24T01:04:13Z |
| publishDate | 2017-02-01 |
| publisher | Zaslavsky O.Yu. |
| record_format | Article |
| series | Zdorovʹe Rebenka |
| spelling | doaj.art-8598c59d999a48c48db1edd8abf05ed72022-12-21T17:23:17ZengZaslavsky O.Yu.Zdorovʹe Rebenka2224-05512307-11682017-02-01121182310.22141/2224-0551.12.1.2017.9501595015The problem of effective and safe treatment of acute respiratory infections in childrenT.A. Kruchko0O.Ya. Tkachenko1V.P. Harshman2O.P. Ivanenko3Higher State Educational Institution of Ukraine «Ukrainian Medical Stomatological Academy», Poltava, UkraineHigher State Educational Institution of Ukraine «Ukrainian Medical Stomatological Academy», Poltava, UkraineHigher State Educational Institution of Ukraine «Ukrainian Medical Stomatological Academy», Poltava, UkraineHigher State Educational Institution of Ukraine «Ukrainian Medical Stomatological Academy», Poltava, UkraineAs the etiological structure of acute respiratory viral infections (ARVI) is polymorphic, the presence of clinical manifestations very rarely allows to establish a connection with a particular pathogen and to prescribe the proper causal treatment. The purpose of this clinical study was to examine the effectiveness of Imupret® in the treatment of acute respiratory viral infections in children (n = 35) of pre-school and primary school age. All patients received symptomatic treatment according to the current order of the Ministry of Healthcare of Ukraine. The main group (n = 18) received additional immunomodulatory herbal drug Imupret®. In order to monitor the course of ARVI, parents filled in the diaries, which included an assessment of nine core symptoms. In children of the main group, we noted improving the clinical index from the 3rd day compared to the controls. Significant differences were observed between patients, when assessing the nature of cough, namely its earlier moistening effect and increased productivity in children, who received additional Imupret® with complete regression in both groups up to the 12th day. The average duration of ARVI in the study group was 6.2 days compared with 8.9 days in the control group. Analyzing the incidence of respiratory diseases, we found out that within three months in the children, who were treated with Imupret®, recurrent episodes were observed in only 28 % of cases, whereas viral infection in children in the control group was registered in almost half of the cases. Imupret® is safe and effective drug of natural origin with a proven mechanism of action for the treatment and prevention of ARVI in children.http://childshealth.zaslavsky.com.ua/article/view/95015acute respiratory infectionschildrenImupret® |
| spellingShingle | T.A. Kruchko O.Ya. Tkachenko V.P. Harshman O.P. Ivanenko The problem of effective and safe treatment of acute respiratory infections in children Zdorovʹe Rebenka acute respiratory infections children Imupret® |
| title | The problem of effective and safe treatment of acute respiratory infections in children |
| title_full | The problem of effective and safe treatment of acute respiratory infections in children |
| title_fullStr | The problem of effective and safe treatment of acute respiratory infections in children |
| title_full_unstemmed | The problem of effective and safe treatment of acute respiratory infections in children |
| title_short | The problem of effective and safe treatment of acute respiratory infections in children |
| title_sort | problem of effective and safe treatment of acute respiratory infections in children |
| topic | acute respiratory infections children Imupret® |
| url | http://childshealth.zaslavsky.com.ua/article/view/95015 |
| work_keys_str_mv | AT takruchko theproblemofeffectiveandsafetreatmentofacuterespiratoryinfectionsinchildren AT oyatkachenko theproblemofeffectiveandsafetreatmentofacuterespiratoryinfectionsinchildren AT vpharshman theproblemofeffectiveandsafetreatmentofacuterespiratoryinfectionsinchildren AT opivanenko theproblemofeffectiveandsafetreatmentofacuterespiratoryinfectionsinchildren AT takruchko problemofeffectiveandsafetreatmentofacuterespiratoryinfectionsinchildren AT oyatkachenko problemofeffectiveandsafetreatmentofacuterespiratoryinfectionsinchildren AT vpharshman problemofeffectiveandsafetreatmentofacuterespiratoryinfectionsinchildren AT opivanenko problemofeffectiveandsafetreatmentofacuterespiratoryinfectionsinchildren |